N-Acetyl Cysteine für Depression-Related Cognitive Dysfunction

Research suggests NAC's glutamate modulation and glutathione restoration may help address cognitive aspects of depression. Evidence is emerging from several clinical studies exploring NAC as an adjunctive treatment.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Ddepression\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Fazit

Key Study Findings

Review

Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox.

Dose: None vs.: None Outcome: None Wirkung: None None

Population: restless legs syndrome

Review

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Dose: None vs.: None Outcome: None Wirkung: None None

Population: None

Other n=24 2 weeks

N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging.

Dose: NAC 100 mg/kg body weight orally daily for 14 days vs.: Placebo Wirkung: significant augmentation of antioxidants and reduction of prooxidants in old rats; downregulation of None

Review

Restless legs syndrome.

Dose: None vs.: None Outcome: quality of life Wirkung: None None

Population: cardiovascular patients

In Vitro

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.

Dose: Valerian extract and valerenic acid vs.: LSD binding Outcome: 5-HT5a receptor binding affinity Wirkung: PE extract IC50 15.7 ng/ml (high affinity) None

Population: None

Key Statistics

Studien

400

Teilnehmer

↑

Positive

Bewertung

Referenced Papers

Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox. Review

Sleep medicine clinics 2021 14 Zitierungen

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Review

Neuroscience and biobehavioral … 2019 45 Zitierungen

N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging. Other

Canadian journal of … 2018 37 Zitierungen

Restless legs syndrome. Review

Handbook of clinical … 2011 8 Zitierungen

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Other

Brain research. Molecular … 2005 160 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:: 600-1,800 mg/day
neuroprotection:: 1,200-2,400 mg/day

Obergrenze: Not established as supplement; 6,000+ mg/day used clinically (IV)

In der Forschung untersuchte Dosierungen

Dosierung	Dauer	Wirkung	N
None	--	Mixed	--
None	--	Positive	--
NAC 100 mg/kg body weight orally daily for 14 days	2 weeks	Positive	24
None	--	Mixed	--
Valerian extract and valerenic acid	--	Positive	--

Beste Einnahmezeit: On empty stomach; split into 2-3 doses; supplement zinc if using long-term

Safety & Side Effects

Gemeldete Nebenwirkungen

⚠ Nausea and vomiting
⚠ Diarrhea
⚠ Unpleasant sulfur taste/smell
⚠ Rare: bronchospasm (inhaled form)
⚠ Long-term use may deplete zinc stores

Bekannte Wechselwirkungen

● Nitroglycerin (may enhance hypotensive effects)
● Activated charcoal (reduces NAC absorption)
● Anticoagulants (theoretical interaction)

Tolerierbare Höchstaufnahmemenge: Not established as supplement; 6,000+ mg/day used clinically (IV)

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does N-Acetyl Cysteine help with Depression-Related Cognitive Dysfunction?

Based on 6 studies with 400 participants, there is limited but promising evidence that N-Acetyl Cysteine may support Depression-Related Cognitive Dysfunction management. Our evidence grade is C (Some Evidence).

How much N-Acetyl Cysteine should I take for Depression-Related Cognitive Dysfunction?

Studies have used various dosages. A commonly studied range is 600-1,800 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of N-Acetyl Cysteine?

Reported side effects may include Nausea and vomiting, Diarrhea, Unpleasant sulfur taste/smell, Rare: bronchospasm (inhaled form). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for N-Acetyl Cysteine and Depression-Related Cognitive Dysfunction?

We rate the evidence as Grade C (Some Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

Andere Inhaltsstoffe für Depression-Related Cognitive Dysfunction

Omega-3 Fatty Acids (DHA/EPA) B Vitamin D C

N-Acetyl Cysteine für andere Beschwerden

Oxidative Stress & Neuroinflammation B Post-Concussion Cognitive Symptoms B

Kurzfazit

Evidence Strength52%

Moderate confidence

Studienübersicht

RCT (0)Meta (0)Other (6)

Alternativen vergleichen

Sehen Sie, wie andere Inhaltsstoffe bei dieser Beschwerde abschneiden.

Alle Inhaltsstoffe ansehen für Depression-Related Cognitive Dysfunction

Mehr erfahren

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.